Search

everythinglearnresearchcommunity

for

Search:↓

Managing menopause symptoms like skin changes and hair thinning involves hormone therapy, procedures, and skincare, with emotional support being important.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Facial hair is crucial for transgender men's gender identity and transition.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Feminizing hormone therapy increases kidney filtration rate.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.